288154-18-7

Basic information

• Product Name: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE
• Synonyms: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE;tert-Butyl 4-amino-4-carbamoylpiperidine-1-carboxylate;1-Boc-4-aMinopiperidine-4-carboxaMide
• CAS NO: 288154-18-7
• Molecular Formula: C₁₁H₂₁N₃O₃
• Molecular Weight: 243.3
• Mol File: 288154-18-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(288154-18-7)
• EPA Substance Registry System: 4-AMINO-1-BOC-PIPERIDINE-4-CARBOXAMIDE(288154-18-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 288154-18-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Amino-1-Boc-piperidine-4-carboxamide is used as a synthetic intermediate for the production of pharmaceutical drugs. Its role in the synthesis process is crucial for creating a variety of bioactive compounds that can be used for medicinal purposes.
Used in Research and Development:
4-Amino-1-Boc-piperidine-4-carboxamide is used as a research chemical, allowing scientists to explore its properties and potential applications in the development of new drugs and therapeutic agents. This helps in advancing the understanding of medicinal chemistry and contributes to the discovery of novel treatments.

Upstream product

• 183673-71-4 4-amino-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid 
• 183673-66-7 N-Fmoc-amino-(4-N-Boc-piperidinyl)carboxylic acid 
• 331281-25-5 4-amino-4-cyano-piperidine-1-carboxylic acid tert-butyl ester 
• 288154-16-5 4-(Benzyloxycarbonylamino)-1-(tert-butoxycarbonyl)-piperidine-4-carboxylic Acid 
• 288154-17-6 1-Boc-4-[Z-amino]piperidine-4-carboxamide 

Downstream Products

• 288154-19-8 1-Boc-4-[(2-phenylethyl)amino]piperidine-4-carboxamide 
• 180386-33-8 1-(2-phenylethyl)-8-Boc-1,3,8-triazaspiro[4.5]decan-4-one 
• 180386-40-7 1-(2-phenylethyl)-8-Boc-1,3,8-triazaspiro[4.5]decan-4-one-3-acetic acid 
• 288154-21-2 1-(2-phenylethyl)-8-Boc-1,3,8-triazaspiro[4.5]dec-2-en-4-one 
• 865626-62-6 4-oxo-2-phenyl-1,3,8-triaza-spiro[4.5]dec-1-ene-8-carboxylic acid tert-butyl ester 
• 1207203-33-5 tert-Butyl 4-carbamoyl-4-[(3,3,3-trifluoropropyl)-amino]piperidine-1-carboxylate 
• 1207203-67-5 1-{[5-(2-Chloro-4-fluorophenyl)-4-{4-[3-(tetrahydro-2H-pyran-2-yloxy)propoxy]phenyl}thien-2-yl]carbonyl}-4-[(3,3,3-trifluoropropyl)amino]piperidine-4-carboxamide 
• 1253925-39-1 2-(2-fluoro-4-trifluoromethyl-phenyl)-4-oxo-1,3,8-triaza-spiro[4.5]dec-1-ene-8-carboxylic acid tert-butyl ester 
• 1579514-51-4 (R)-methyl 2-(4-bromophenyl)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1579514-39-8 4-tert-butyl 4-(4-bromobenzamido)-4-carbamoylpiperidine-1-carboxylate 
• 1579514-47-8 (S)-methyl 2-(4-bromophenyl)-3-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)methyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 

Relevant articles and documents

Spiro compound

The invention discloses a spiro compound, application thereof and a pharmaceutical composition containing the spiro compound. The structure of the compound is shown as a formula I, and the compound has a good inhibition effect on RET kinase.

RET inhibitor

The invention discloses a compound, application thereof and a pharmaceutical composition containing the compound. The structure of the compound is shown as a formula I, and the compound has a good inhibition effect on RET kinase.

SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

ACETYL CoA CARBOXYLASE INHIBITORS

The present invention relates to acetyl coenzyme-A carboxylase (""ACC"") inhibiting compounds of the formula wherein the variables are as defined herein. In particular, the present invention relates to ACC1 and/or ACC2 inhibitors, compositions of matter,

CGRP RECEPTOR ANTAGONISTS

The present invention is directed to compounds of Formula I: Formula I: I and Formula II: (where variables R1, R2, R3, R4, A, B, J, Q, T, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

CGRP RECEPTOR ANTAGONISTS

Compounds of Formula (I): and Formula (II): (where variables R2, R4, A, B, D, W, X, Y and Z are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

A rational approach to the design and synthesis of a new bradykinin B1 receptor antagonist

We have previously synthesized a potent and selective B1 bradykinin receptor antagonist, JMV1645 (H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH), containing a dipeptide mimetic ((3S)-amino-5-carbonylmethyl-2,3-dihydro-1,5- benzothiazepin-4(5H)-one (D-B